prostate-cancer

Documents about prostate-cancer

• Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour#803139ClinicalTrials.gov
• Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels#829585ClinicalTrials.gov
• Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007#832927ClinicalTrials.gov
• Combination Study of Antibiotics With Enzalutamide (PROMIZE)#363628ClinicalTrials.gov
• The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.#653321NCBI PubMed Central
• miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.#685343Lund University Publications
• A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy#140973ClinicalTrials.gov
• Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer#841414ClinicalTrials.gov
• Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA#303581ClinicalTrials.gov
• Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer#826214ClinicalTrials.gov
• Using Supervised Machine Learning Algorithms to Predict Prostate Cancer Cases: A Case of Men of African Descent Carcinoma of the Prostate Consortium (MADCaP), South Africa#447672WIReDSpace
• Collection of Blood From Patients With Cancer#833376ClinicalTrials.gov
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries#6803OpenAlex
• DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers#256862ClinicalTrials.gov
• Advancements and Challenges in Computer-Assisted Medical Interventions for Image-Guided Prostate Cancer Treatments#153813HAL (France)
• A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation#651243ClinicalTrials.gov
• A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer#807160ClinicalTrials.gov
• Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study#634548Dipòsit Digital de la Universitat de Barcelona
• Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized 13C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures#609437eScholarship
• Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations#162447ClinicalTrials.gov
• TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)#838127ClinicalTrials.gov
• Diabetes Might Shape Vasculature, Tumor Dissemination and Circulating Inflammation Marker Profiles in Prostate Cancer.#234298bioRxiv / medRxiv
• Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia#833306ClinicalTrials.gov
• Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer#226262ClinicalTrials.gov
• The glycobiology of prostate cancer: an update.#326956NCBI PubMed Central
• Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer#356640ClinicalTrials.gov
• To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen#467624ClinicalTrials.gov
• ADT Exercise Trial and Economic Analysis#806855ClinicalTrials.gov
• Study of Dasatinib, Androgen Deprivation Therapy and Radiation#807086ClinicalTrials.gov
• Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older#208283ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer#332745ClinicalTrials.gov
• The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis#4635Europe PMC
• Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications#202784IRIS
• Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort#284519IRIS
• The Effectiveness of Treatment Options for Localized Prostate Cancer: A Meta-Analysis of Cross-Sectional and Cohort Studies#462413Scholarly Commons
• Prostate Cancer Genetic Risk Evaluation and Screening Study#801081ClinicalTrials.gov
• Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT#812310ClinicalTrials.gov
• An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care#840033ClinicalTrials.gov
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors#811070ClinicalTrials.gov
• Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy#841447ClinicalTrials.gov
• Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers#346922ClinicalTrials.gov
• Serial MRI Scans During Radiation Therapy#835961ClinicalTrials.gov
• PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer#127572ClinicalTrials.gov
• Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines#256887ClinicalTrials.gov
• An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...#837455ClinicalTrials.gov
• MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour#845831ClinicalTrials.gov
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance#390923ClinicalTrials.gov
• Navigation Programs Relevant for African American Men with Prostate Cancer: A Scoping Review Protocol#228604Scholar Commons
• Rapid decentralized prostate cancer risk stratification by portable liquid biopsy analysis within a clinical biosensor validation framework#389800Research Online
• Table 1_The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.docx#471743Figshare